+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

K/DOQI practice guidelines for bone metabolism and disease in chronic kidney disease: another opportunity for renal dietitians to take a leadership role in improving outcomes for patients with chronic kidney disease



K/DOQI practice guidelines for bone metabolism and disease in chronic kidney disease: another opportunity for renal dietitians to take a leadership role in improving outcomes for patients with chronic kidney disease



Journal of Renal Nutrition 15(2): 265-274




(PDF emailed within 0-6 h: $19.90)

Accession: 049433230

Download citation: RISBibTeXText

PMID: 15827902

DOI: 10.1053/j.jrn.2005.01.002


Related references

Consequences of the implementation of K/DOQI Clinical Practice Guidelines for Bone Metabolism and Disease in Chronic Kidney Disease in a population of patients on chronic hemodialysis. Journal of Nephrology 20(4): 453-461, 2007

Implementation of 'K/DOQI Clinical Practice Guidelines for Bone Metabolism and Disease in Chronic Kidney Disease' after the introduction of cinacalcet in a population of patients on chronic haemodialysis. Nephrology, Dialysis, Transplantation 22(6): 1639-1644, 2007

K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. American Journal of Kidney Diseases 42(4 Suppl 3): S1-201, 2003

Outlines of K/DOQI Clinical Practice Guidelines for Bone Metabolism and Disease in Chronic Kidney Disease. Clinical Calcium 14(5): 693-697, 2004

Treatment of bone disease in chronic kidney disease and in renal transplant recipients under K/DOQI clinical practice guidelines. Clinical Calcium 14(5): 710-718, 2004

K/DOQI guidelines for bone metabolism and disease in chronic kidney disease patients: some therapeutic implications. Seminars in Dialysis 17(5): 349-350, 2004

Kidney Disease: Improving Global Outcomes guidelines on anaemia management in chronic kidney disease: a European Renal Best Practice position statement. Nephrology, Dialysis, Transplantation 28(6): 1346-1359, 2014

Adaptation and implementation of the "Kidney Disease: Improving Global Outcomes (KDIGO)" guidelines for evaluation and management of mineral and bone disorders in chronic kidney disease for practice in the Middle East countries. Saudi Journal of Kidney Diseases and Transplantation 25(1): 133-148, 2014

K-DOQI guidelines for calcium and phosphorus metabolism in chronic kidney disease: outcomes, compliance and new drugs for treatment. Nefrologia 27(6): 670-673, 2008

Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder: Synopsis of the Kidney Disease: Improving Global Outcomes 2017 Clinical Practice Guideline Update. Annals of Internal Medicine 168(6): 422-430, 2018

Clinical practice guidelines for managing dyslipidemias in kidney transplant patients: a report from the Managing Dyslipidemias in Chronic Kidney Disease Work Group of the National Kidney Foundation Kidney Disease Outcomes Quality Initiative. American Journal of Transplantation 4 Suppl 7: 13-53, 2004

National Kidney Foundation's Kidney Disease Outcomes Quality Initiative clinical practice guidelines for chronic kidney disease in children and adolescents: evaluation, classification, and stratification. Pediatrics 111(6 Pt 1): 1416-1421, 2003

A European Renal Best Practice (ERBP) position statement on the Kidney Disease: Improving Global Outcomes (KDIGO) clinical practice guideline for the management of blood pressure in non-dialysis-dependent chronic kidney disease: an endorsement with some caveats for real-life application. Nephrology, Dialysis, Transplantation 29(3): 490-496, 2015

[guidelines for the Prevention, Monitoring and Therapy of Chronic Kidney Disease-Metabolic Bone Disease in Patients with Chronic Kidney Disease. Lijecnicki Vjesnik 138(5-6): 107-120, 2016

Achievement of 2009 and 2017 Kidney Disease: Improving Global Outcomes mineral and bone targets and survival in a French cohort of chronic kidney disease Stages 4 and 5 non-dialysis patients. Clinical Kidney Journal 11(5): 710-719, 2018